NASDAQ:TECH

Bio-techne Stock News

Healthcare > Biotechnology

Buy TECH

*Your capital is at risk

$56.26

+0.650 (+1.17%)

At Close: Jun 23, 2026

Techne (TECH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

10:31am, Wednesday, 04'th Feb 2026

While the top- and bottom-line numbers for Techne (TECH) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

08:41am, Wednesday, 04'th Feb 2026

Techne (TECH) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.42 per share a year ago.

Biotech firm Bio-Techne beats quarterly estimates on strength in key unit

08:11am, Wednesday, 04'th Feb 2026

Biotech firm Bio-Techne beat analysts' estimates for second-quarter revenue and profit on Wednesday, helped by robust demand for its products used in drug development.

Bio-Techne Declares Dividend

06:30am, Wednesday, 04'th Feb 2026

MINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December

Bio-Techne Releases Second Quarter Fiscal 2026 Results

06:30am, Wednesday, 04'th Feb 2026

MINNEAPOLIS, Feb. 4, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ending December 31, 2025. Second Quarter FY2026 Highlights S

Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative

06:30am, Monday, 02'nd Feb 2026

Fully defined, synthetic ECM designed to improve reproducibility and reduce lot-to-lot variability Supports standardization of scalable 3D stem cell and organoid workflows Synthetic alternative to t

CSLLY or TECH: Which Is the Better Value Stock Right Now?

12:40pm, Friday, 30'th Jan 2026

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with CSL Limited Sponsored ADR (CSLLY) and Techne (TECH). But which of these two stocks offers value investors a be

Bio-Techne's Q2 Earnings on Deck: What's in Store for the Stock?

09:46am, Friday, 30'th Jan 2026

TECH is set to report Q2 results on Feb. 4, with EPS seen at 43 cents and revenues at $292M as tariffs, NIH funding and segment shifts shape outlook.

Bio-Techne Corp (NASDAQ:TECH) Receives Average Recommendation of “Moderate Buy” from Analysts

01:29am, Thursday, 29'th Jan 2026

Shares of Bio-Techne Corp (NASDAQ: TECH - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the sixteen analysts that are covering the firm, Marketbeat reports. Two researc

Eaton Vance Worldwide Health Sciences Fund Reduces Stake in Novo Nordisk AS by 49.25%

03:01pm, Wednesday, 28'th Jan 2026

Exploring Strategic Moves in the Health Sciences Sector Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) recently submitted its N-PORT filing for

Madison Mid Cap Fund Q4 2025 Portfolio Activity

01:19pm, Wednesday, 28'th Jan 2026

We added four new investments to the portfolio: Bio-Techne, ServiceTitan, A.O. Smith, and MSA Safety. We sold two holdings, Trex and Microchip Technology. We trimmed our position in Amphenol during th

Bio-Techne Launches Simple Plex Ultra-Sensitive Assays on Ella Platform to Enable Femtogram-Level Detection of Neurological Biomarkers

06:30am, Wednesday, 28'th Jan 2026

Detects low-abundance proteins in blood at femtogram concentrations for earlier disease insights Supports research in Alzheimer's, ALS, MS, Parkinson's Disease, and Traumatic Brain Injury with valida

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by